• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » NeuroWave wins 510(k) for brain monitor

NeuroWave wins 510(k) for brain monitor

December 8, 2010 By MedCity News

MedCity News logo

Medical device startup NeuroWave Systems Inc. received regulatory clearance from the Food & Drug Administration to begin selling a brain activity monitoring system.

The Cleveland Heights, Ohio-based company’s NeuroFAST Monitoring System is intended for use in hospital operating rooms, emergency departments and intensive care units with patients who’ve experienced some sort of brain trauma, such as seizures. The system acquires and displays electroencephalographic signals — which are produced by neurons firing in the brain — obtained from noninvasive electrodes placed on a patient’s forehead, according to a statement from the company.

“It’s the first FDA-approved device that NeuroWave has, so that’s a real big deal,” said Bob Schmidt, NeuroWave’s chairman. “This is a big step for us as a growing company.”

In June, the company received European regulatory clearance to begin selling its NeuroSense anesthesia monitor, which is similar to the NeuroFAST system but operates on more-sophisticated algorithms, according to Schmidt.

Because the company has been focusing its efforts on ramping up European sales, NeuroWave isn’t yet ready to detail its plans for commercializing the NeuroFAST device in the U.S., Schmidt said.

510(k) clearance from the FDA has been a long time coming for NeuroWave. The company began developing its brain-monitoring devices in 2003, when it licensed the technology from co-inventor and now NeuroWave president Tatjana Zikov.

NeuroWave was spun off in 2008 from Cleveland Medical Devices, which was founded by Schmidt. CleveMed develops biomedical signal processing and instrumentation devices for sleep and movement disorders, like Parkinson’s.

So far, NeuroWave has used federal grants and contracts and at least one Ohio grant to develop its brain monitoring technologies — and not a penny from investors.

The market for brain wave-monitoring devices used during anesthesia is estimated at more than $1 billion a year and growing, according to CleveMed. The market is dominated by Aspect Medical Systems Inc. of Norwood, Mass., according to Neurotech Business Report. Covidien plc acquired Aspect in November 2009 for $210 million.

Filed Under: Business/Financial News, Neurological, News Well Tagged With: Anesthesia, NeuroWave Systems Inc.

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy